论文部分内容阅读
冠状动脉血运重建是冠心病的有效治疗手段,对于左主干及复杂血管病变的冠心病患者,如何选择血运重建策略目前仍存在争议。SYNTAX评分经过5年临床实践证明是评价预后较好的工具,但仅限于冠状动脉解剖评价,具有临床局限性。SYNTAXⅡ评分将SYNTAX评分及临床相关危险因素包含在内,自2013年提出后,近年来国外大规模临床实验研究进一步证实了SYNTAXⅡ评分是评价预后的良好工具,也在现实世界中为患者血运重建策略的选择提供了依据。
Coronary artery revascularization is an effective treatment for coronary heart disease. There is still controversy on how to choose the revascularization strategy for patients with coronary artery disease of the left main trunk and complicated vascular lesions. SYNTAX score after 5 years of clinical practice has proved to be a good tool to evaluate the prognosis, but limited to the anatomy of coronary arteries, with clinical limitations. The SYNTAX II score includes the SYNTAX score and clinically relevant risk factors. Since it was proposed in 2013, the large-scale clinical trial abroad in recent years has further confirmed that the SYNTAX II score is a good tool to evaluate the prognosis and is also useful in the real world for revascularization The choice of strategy provides the basis.